Trial Profile
Pioglitazone in Alzheimer Disease Progression.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2010
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 13 Sep 2010 Results published in the Archives of Neurology.
- 26 Sep 2009 New trial record